Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.
Open Access
- 1 December 1993
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (12) , 1126-1128
- https://doi.org/10.1136/jcp.46.12.1126
Abstract
The staining patterns obtained with two antibodies against proliferating cell nuclear antigen (PC10 and 19A2) and another cell cycle associated antibody (KiS1) were compared with each other and with a number of established prognostic markers of breast carcinoma. Although PC10 and 19A2 staining patterns were similar, only the latter was significantly associated with KiS1 antibody staining. These findings suggest that the two PCNA antibodies detect different epitopes. KiS1 was the only antibody to show an association with S phase fraction measured by flow cytometry (p < 0.001). It was also associated with histological grade (p = 0.003), oestrogen receptors (p = 0.045), and DNA index (p = 0.007). PC10 showed no association with any of the markers of prognosis, while 19A2 was associated with histological grade (p = 0.017) and oestrogen receptors (p = 0.043). The two PCNA antibodies do not seem to be of value in measuring proliferative activity nor do they seem to be associated with established markers of prognosis in breast cancer.Keywords
This publication has 11 references indexed in Scilit:
- Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivoBritish Journal of Cancer, 1994
- Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cellsBritish Journal of Cancer, 1993
- PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma.1992
- KiSl—A novel monoclonal antibody which recognizes proliferating cells: Evaluation of its relationship to prognosis in mammary carcinomaThe Journal of Pathology, 1992
- PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.Journal of Clinical Pathology, 1992
- A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AGNOR) staining, and histological grading in gastrointestinal stromal tumoursThe Journal of Pathology, 1992
- Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10European Journal Of Cancer, 1992
- Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.Journal of Clinical Pathology, 1991
- The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosisHistopathology, 1991
- Correlation of proliferative activity in breast tissue using PCNA/cyclinHuman Pathology, 1990